FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043347751> ?p ?o ?g. }

• W2043347751 endingPage "648" @default.
• W2043347751 startingPage "641" @default.
• W2043347751 abstract "The success of arsenic trioxide (ATO) in treatment of acute promyelocytic leukemia (APL) attracts a great deal of attention to researchers to explore its activity of anti-leukemia. However, ATO has unavailable effect on chronic myeloid leukemia (CML), especially multidrug resistant (MDR)-CML, unless using high concentration. Realgar (As4S4) has been employed in Chinese traditional medicine for 1500 years. Research evidences confirmed realgar has similar effect on treating with APL as ATO, but the problem of large dose and long period in the CML/MDR-CML treatment still exist. By using a microbial leaching process with Acidithiobacillus ferrooxidans, we obtained realgar transforming solution (RTS) which showed significantly higher extent in inhibiting CML cell line K562 and MDR-CML cell line K562/ADM, and then trigger apoptosis. Both K562 and K562/ADM showed arsenic-dose-dependent effect on RTS. Interestingly, the overexpression of MDR1 mRNA and P-glucoprotein (P-gp) in K562/ADM cells were down-regulated by RTS, where there are no obvious effects on ATO and realgar and arsenic can be subsequently accumulated in K562/ADM cells efficiently. The intracellular accumulation of arsenic in K562/ADM cells treated with RTS for 4 h was 2-fold and 16-folds higher than those treated with realgar or ATO. Meanwhile, Western blot analysis of AQP9, the main transporter of arsenic, was increased by RTS treatment particularly in K562/ADM. Thus, these results suggested that the effect from a certain arsenical or a variety of arsenicals in RTS might be a promising candidate both for treating CML/MDR-CML alone and as combinations with currently used anti-CML/MDR-CML drug, although arsenical forms in RTS are undefined." @default.
• W2043347751 created "2016-06-24" @default.
• W2043347751 creator A5000747347 @default.
• W2043347751 creator A5006822602 @default.
• W2043347751 creator A5024025818 @default.
• W2043347751 creator A5025970866 @default.
• W2043347751 creator A5052813770 @default.
• W2043347751 creator A5066529733 @default.
• W2043347751 date "2013-01-01" @default.
• W2043347751 modified "2023-10-18" @default.
• W2043347751 title "Reversal Effect of Arsenic Sensitivity in Human Leukemia Cell Line K562 and K562/ADM Using Realgar Transforming Solution" @default.
• W2043347751 cites W1530879923 @default.
• W2043347751 cites W1852171125 @default.
• W2043347751 cites W1866406062 @default.
• W2043347751 cites W1872445023 @default.
• W2043347751 cites W1966047754 @default.
• W2043347751 cites W1967088245 @default.
• W2043347751 cites W1975259310 @default.
• W2043347751 cites W1984105235 @default.
• W2043347751 cites W1990178301 @default.
• W2043347751 cites W2005839331 @default.
• W2043347751 cites W2013697282 @default.
• W2043347751 cites W2030644377 @default.
• W2043347751 cites W2038058372 @default.
• W2043347751 cites W2041480637 @default.
• W2043347751 cites W2043534420 @default.
• W2043347751 cites W2047646710 @default.
• W2043347751 cites W2047735969 @default.
• W2043347751 cites W2071479387 @default.
• W2043347751 cites W2071709986 @default.
• W2043347751 cites W2074644527 @default.
• W2043347751 cites W2146450867 @default.
• W2043347751 cites W2156663446 @default.
• W2043347751 cites W2163082407 @default.
• W2043347751 cites W2188624640 @default.
• W2043347751 cites W2318404487 @default.
• W2043347751 cites W2341663969 @default.
• W2043347751 cites W2353246399 @default.
• W2043347751 cites W2373547432 @default.
• W2043347751 cites W2392734068 @default.
• W2043347751 doi "https://doi.org/10.1248/bpb.b12-01015" @default.
• W2043347751 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23358330" @default.
• W2043347751 hasPublicationYear "2013" @default.
• W2043347751 type Work @default.
• W2043347751 sameAs 2043347751 @default.
• W2043347751 citedByCount "11" @default.
• W2043347751 countsByYear W20433477512015 @default.
• W2043347751 countsByYear W20433477512016 @default.
• W2043347751 countsByYear W20433477512017 @default.
• W2043347751 countsByYear W20433477512018 @default.
• W2043347751 countsByYear W20433477512019 @default.
• W2043347751 crossrefType "journal-article" @default.
• W2043347751 hasAuthorship W2043347751A5000747347 @default.
• W2043347751 hasAuthorship W2043347751A5006822602 @default.
• W2043347751 hasAuthorship W2043347751A5024025818 @default.
• W2043347751 hasAuthorship W2043347751A5025970866 @default.
• W2043347751 hasAuthorship W2043347751A5052813770 @default.
• W2043347751 hasAuthorship W2043347751A5066529733 @default.
• W2043347751 hasBestOaLocation W20433477511 @default.
• W2043347751 hasConcept C104317684 @default.
• W2043347751 hasConcept C171122931 @default.
• W2043347751 hasConcept C178790620 @default.
• W2043347751 hasConcept C185592680 @default.
• W2043347751 hasConcept C190283241 @default.
• W2043347751 hasConcept C199289684 @default.
• W2043347751 hasConcept C203014093 @default.
• W2043347751 hasConcept C2776601000 @default.
• W2043347751 hasConcept C2778461978 @default.
• W2043347751 hasConcept C2778548315 @default.
• W2043347751 hasConcept C2778729363 @default.
• W2043347751 hasConcept C2779495234 @default.
• W2043347751 hasConcept C2780386689 @default.
• W2043347751 hasConcept C2781121885 @default.
• W2043347751 hasConcept C502230775 @default.
• W2043347751 hasConcept C502942594 @default.
• W2043347751 hasConcept C55493867 @default.
• W2043347751 hasConcept C71924100 @default.
• W2043347751 hasConcept C98274493 @default.
• W2043347751 hasConceptScore W2043347751C104317684 @default.
• W2043347751 hasConceptScore W2043347751C171122931 @default.
• W2043347751 hasConceptScore W2043347751C178790620 @default.
• W2043347751 hasConceptScore W2043347751C185592680 @default.
• W2043347751 hasConceptScore W2043347751C190283241 @default.
• W2043347751 hasConceptScore W2043347751C199289684 @default.
• W2043347751 hasConceptScore W2043347751C203014093 @default.
• W2043347751 hasConceptScore W2043347751C2776601000 @default.
• W2043347751 hasConceptScore W2043347751C2778461978 @default.
• W2043347751 hasConceptScore W2043347751C2778548315 @default.
• W2043347751 hasConceptScore W2043347751C2778729363 @default.
• W2043347751 hasConceptScore W2043347751C2779495234 @default.
• W2043347751 hasConceptScore W2043347751C2780386689 @default.
• W2043347751 hasConceptScore W2043347751C2781121885 @default.
• W2043347751 hasConceptScore W2043347751C502230775 @default.
• W2043347751 hasConceptScore W2043347751C502942594 @default.
• W2043347751 hasConceptScore W2043347751C55493867 @default.
• W2043347751 hasConceptScore W2043347751C71924100 @default.
• W2043347751 hasConceptScore W2043347751C98274493 @default.
• W2043347751 hasIssue "4" @default.

• next